Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience.
Molica M, Mazzone C, Niscola P, Carmosino I, Di Veroli A, De Gregoris C, Bonanni F, Perrone S, Cenfra N, Fianchi L, Piccioni AL, Spadea A, Luzi G, Mengarelli A, Cudillo L, Maurillo L, Pagano L, Breccia M, Rigacci L, De Fabritiis P. Molica M, et al. Among authors: mengarelli a. Cancers (Basel). 2022 Oct 6;14(19):4897. doi: 10.3390/cancers14194897. Cancers (Basel). 2022. PMID: 36230820 Free PMC article.
Standard- versus high-dose lenograstim in adults with hematologic malignancies for peripheral blood progenitor cell mobilization.
Romeo A, Chierichini A, Spagnoli A, Vittori M, Vacca M, Gozzer M, Spadea A, Anaclerico B, Dessanti ML, D'Andrea M, Toglia G, Annino L, Petti MC, Mengarelli A, Arcese W; Rome Transplant Network. Romeo A, et al. Among authors: mengarelli a. Transfusion. 2010 Nov;50(11):2432-46. doi: 10.1111/j.1537-2995.2010.02723.x. Transfusion. 2010. PMID: 20553434
A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: clinical significance of treatment intensity and comprehensive geriatric assessment.
Marchesi F, Cenfra N, Altomare L, Dessanti ML, Mecarocci S, Cerchiara E, Rago A, D'Andrea M, Tomarchio V, Olimpieri OM, Tirindelli MC, Mengarelli A, Petti MC, Avvisati G, Cimino G. Marchesi F, et al. Among authors: mengarelli a. J Geriatr Oncol. 2013 Jul;4(3):242-8. doi: 10.1016/j.jgo.2013.04.003. Epub 2013 May 7. J Geriatr Oncol. 2013. PMID: 24070462
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network.
Marchesi F, Mengarelli A, Giannotti F, Tendas A, Anaclerico B, Porrini R, Picardi A, Cerchiara E, Dentamaro T, Chierichini A, Romeo A, Cudillo L, Montefusco E, Tirindelli MC, De Fabritiis P, Annino L, Petti MC, Monarca B, Arcese W, Avvisati G; Rome Transplant Network. Marchesi F, et al. Among authors: mengarelli a. Transpl Infect Dis. 2014 Feb;16(1):158-64. doi: 10.1111/tid.12162. Epub 2013 Nov 12. Transpl Infect Dis. 2014. PMID: 24215479
Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study.
Marchesi F, Pimpinelli F, Dessanti ML, Gumenyuk S, Palombi F, Pisani F, Romano A, Spadea A, Maschio M, Ensoli F, Mengarelli A. Marchesi F, et al. Among authors: mengarelli a. Transpl Infect Dis. 2014 Dec;16(6):1032-8. doi: 10.1111/tid.12309. Epub 2014 Nov 5. Transpl Infect Dis. 2014. PMID: 25369809
360 results